HIV viral load suppression among people with mental disorders at two urban HIV Clinics in Uganda: a parallel convergent mixed methods study using the Social Ecological Model.
| العنوان: | HIV viral load suppression among people with mental disorders at two urban HIV Clinics in Uganda: a parallel convergent mixed methods study using the Social Ecological Model. |
|---|---|
| المؤلفون: | Ndagire R; Clinical Epidemiology Unit, College of Health Sciences, Makerere University., Wangi RN; Clinical Epidemiology Unit, College of Health Sciences, Makerere University., Ojiambo KO; Clinical Epidemiology Unit, College of Health Sciences, Makerere University., Nangendo J; Clinical Epidemiology Unit, College of Health Sciences, Makerere University., Nakku J; Butabika National Mental Referral Hospital., Muyinda H; Child Health Development Center (CHDC)., Semitala FC; Makerere University Joint AIDS Program (MJAP), Makerere University. |
| المصدر: | Research square [Res Sq] 2023 May 09. Date of Electronic Publication: 2023 May 09. |
| نوع المنشور: | Preprint |
| اللغة: | English |
| بيانات الدورية: | Country of Publication: United States NLM ID: 101768035 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: Res Sq Subsets: PubMed not MEDLINE |
| مستخلص: | Background Uganda adopted and implemented the Universal Test and Treat (UTT) guidelines in 2017, which require HIV-infected persons to be initiated on antiretroviral therapy (ART) at any CD4 + cell count, and to be routinely monitored for viral load to assess response to ART. However, there is paucity of data on viral load suppression (VLS) among people living with HIV (PLHIV) with mental disorders. We conducted a parallel convergent mixed methods study to determine HIV VLS among people with a mental disorder and explored the socio-cultural determinants of VLS at Butabika hospital and Mulago (ISS) HIV Clinics in Uganda. Methods We conducted a retrospective medical records review; seven key informant interviews (KII) among purposively selected healthcare providers and 12 in-depth interviews (IDI) among clinically stable PLHIV with a mental disorder. Data was collected on demographics, mental disorder, ART, viral load status, social support, stigma, and disclosure of HIV status. Quantitative data was analysed using descriptive statistics and modified Poisson regression, while Inductive thematic analysis was used for the qualitative data. Results Of the 240 PLHIV with a mental disorder who were enrolled, 161 (67.1%) were female with mean age 38.9 (± 11.2) years. Overall, 88.8% (95% Cl: 84.0% - 92.2%) achieved VLS. Age (aPR = 1.01, 95%Cl = 1.00-1.01), male gender (aPR = 0.95, 95%Cl = 0.95-0.95), divorced (aPR = 0.89, 95%Cl = 0.87-0.91), widowed (aPR = 0.84, 95%Cl = 0.79-0.90), baseline CD4 count < 200 (aPR = 0.89, 95%Cl = 0.82-0.95), and fair (85-94%) ART adherence level (aPR = 0.68, (95%Cl = 0.54-0.87) were associated with HIV VLS. Social support from family members, knowledge of impact of negative thoughts on VLS, fear of breaking up with partners and compassionate healthcare providers positively influenced VLS. Stigma and discrimination from the community, self-perceived stigma hindering social relations, socio-economic challenges and psychiatric drug stock-outs negatively affected VLS. Conclusion and recommendations HIV VLS among PLHIV with mental disorders at institutions that provide integrated HIV and mental health care is still below the UNAIDS 95% target. Health promotion messaging focusing on benefits of VLS and countering stigma to create a safe environment; and active involvement of family members in care could improve HIV treatment outcomes for PLHIV with mental disorders. |
| التعليقات: | Update in: AIDS Res Ther. 2023 Sep 19;20(1):68. (PMID: 37726822) |
| References: | BMC Infect Dis. 2017 May 3;17(1):326. (PMID: 28468608) Community Ment Health J. 2018 Nov;54(8):1146-1153. (PMID: 29752639) Int J Ment Health Syst. 2013 Jul 17;7:20. (PMID: 23866085) Ann Behav Med. 2014 Jun;47(3):259-69. (PMID: 24234601) AIDS Behav. 2015 Feb;19(2):283-90. (PMID: 25164375) J Acquir Immune Defic Syndr. 2020 Apr 1;83(4):340-344. (PMID: 32097193) AIDS Behav. 2019 Aug;23(8):2025-2036. (PMID: 30343422) AIDS. 2011 May 15;25(8):1113-8. (PMID: 21399478) Am J Public Health. 2017 Jun;107(6):863-869. (PMID: 28426316) Lancet Glob Health. 2020 Oct;8(10):e1326-e1334. (PMID: 32971055) Infect Dis (Auckl). 2020 Nov 05;13:1178633720970632. (PMID: 33223836) AIDS Behav. 2017 Jun;21(6):1632-1640. (PMID: 27251436) AIDS Behav. 2020 Dec;24(12):3522-3532. (PMID: 32415615) Psychosom Med. 2022 Oct 1;84(8):914-923. (PMID: 36162067) J Virus Erad. 2016 Apr 01;2(2):94-101. (PMID: 27482442) Curr HIV/AIDS Rep. 2014 Sep;11(3):291-307. (PMID: 25038748) AIDS Care. 2017 Apr;29(4):469-480. (PMID: 27456040) J Int AIDS Soc. 2020 Dec;23(12):e25644. (PMID: 33283916) AIDS Patient Care STDS. 2015 Jan;29 Suppl 1:S27-35. (PMID: 25458205) Int J Infect Dis. 2020 Aug;97:151-158. (PMID: 32497804) AIDS. 2002 Mar 29;16(5):767-74. (PMID: 11964533) PLoS One. 2020 Dec 15;15(12):e0244066. (PMID: 33320900) J Acquir Immune Defic Syndr. 2020 Dec 15;85(5):561-570. (PMID: 32991336) AIDS Behav. 2018 Mar;22(3):752-764. (PMID: 27990582) BMC Infect Dis. 2016 Oct 28;16(1):614. (PMID: 27793124) Health Psychol. 2018 Jun;37(6):574-585. (PMID: 29781655) Implement Sci Commun. 2021 Oct 20;2(1):121. (PMID: 34670624) Int J Qual Health Care. 2007 Dec;19(6):349-57. (PMID: 17872937) Int J STD AIDS. 2012 Jan;23(1):44-7. (PMID: 22362687) J Acquir Immune Defic Syndr. 2007 Oct 1;46(2):187-93. (PMID: 17693883) AIDS Behav. 2016 Aug;20(8):1603-8. (PMID: 26809193) AIDS Res Ther. 2018 Jan 16;15(1):1. (PMID: 29338735) |
| معلومات مُعتمدة: | D43 TW011304 United States TW FIC NIH HHS |
| تواريخ الأحداث: | Date Created: 20230522 Latest Revision: 20231012 |
| رمز التحديث: | 20240628 |
| مُعرف محوري في PubMed: | PMC10197750 |
| DOI: | 10.21203/rs.3.rs-2897447/v1 |
| PMID: | 37214962 |
| قاعدة البيانات: | MEDLINE |
كن أول من يترك تعليقا!